{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:19:14Z","timestamp":1792084754440,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T00:00:00Z","timestamp":1321920000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2377-11-148","type":"journal-article","created":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T19:15:33Z","timestamp":1321989333000},"source":"Crossref","is-referenced-by-count":82,"title":["Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research"],"prefix":"10.1186","volume":"11","author":[{"given":"Lucette A","family":"Cysique","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward K","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce J","family":"Brew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,22]]},"reference":[{"key":"551_CR1","first-page":"5","volume":"2011","author":"E Wright","year":"2011","unstructured":"Wright E: Neurocognitive impairment and neuroCART. Curr Opin HIV AIDS. 2011, 2011: 5-","journal-title":"Curr Opin HIV AIDS"},{"issue":"18","key":"551_CR2","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","volume":"69","author":"A Antinori","year":"2007","unstructured":"Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, et al: Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007, 69 (18): 1789-1799. 10.1212\/01.WNL.0000287431.88658.8b.","journal-title":"Neurology"},{"issue":"7","key":"551_CR3","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1212\/WNL.0b013e31820c3089","volume":"76","author":"E Lanoy","year":"2011","unstructured":"Lanoy E, Guiguet M, Bentata M, Rouveix E, Dhiver C, Poizot-Martin I, Costagliola D, Gasnault J: Survival after neuroAIDS: association with antiretroviral CNS Penetration-Effectiveness score. Neurology. 2011, 76 (7): 644-651. 10.1212\/WNL.0b013e31820c3089.","journal-title":"Neurology"},{"key":"551_CR4","unstructured":"Antiretroviral therapy. [ http:\/\/www.who.int\/hiv\/topics\/treatment\/en\/ ]"},{"key":"551_CR5","volume-title":"ASHM: 2010; Sydney, Australia","author":"ASHM","year":"2010","unstructured":"ASHM: Proceedings Report - Antiretroviral Guidelines Consensus Discussion (2010). ASHM: 2010; Sydney, Australia. 2010, ASHM, [ http:\/\/www.ashm.org.au\/default2.asp?active_page_id=252 ]"},{"key":"551_CR6","first-page":"4","volume":"4","author":"V Dahl","year":"2009","unstructured":"Dahl V, Josefsson L, Palmer S: HIV reservoirs, latency, and reactivation: Prospects for eradication. Antiviral Res. 2009, 4: 4-","journal-title":"Antiviral Res"},{"issue":"14","key":"551_CR7","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1097\/QAD.0b013e32828e4e27","volume":"21","author":"KR Robertson","year":"2007","unstructured":"Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, McArthur JC, Collier AC, Evans SR, Ellis RJ: The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS. 2007, 21 (14): 1915-1921. 10.1097\/QAD.0b013e32828e4e27.","journal-title":"AIDS"},{"key":"551_CR8","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1097\/00002030-200009080-00010","volume":"14","author":"P Cunningham","year":"2000","unstructured":"Cunningham P, Smith D, Satchell C, Cooper DA, Brew B: Evidence for independant development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid. AIDS. 2000, 14: 1949-1954. 10.1097\/00002030-200009080-00010.","journal-title":"AIDS"},{"key":"551_CR9","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1097\/00002030-199906180-00008","volume":"13","author":"S Staprans","year":"1999","unstructured":"Staprans S, Marlowe N, Glidden D, Novakovic-Agopian T, Grant RM, Heyes M, Aweeka F, Deeks S, Price RW: Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection. AIDS. 1999, 13: 1051-1061. 10.1097\/00002030-199906180-00008.","journal-title":"AIDS"},{"issue":"3","key":"551_CR10","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1128\/JVI.79.3.1772-1788.2005","volume":"79","author":"MC Strain","year":"2005","unstructured":"Strain MC, Letendre S, Pillai SK, Russell T, Ignacio CC, Gunthard HF, Good B, Smith DM, Wolinsky SM, Furtado M, et al: Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. Journal of Virology. 2005, 79 (3): 1772-1788. 10.1128\/JVI.79.3.1772-1788.2005.","journal-title":"Journal of Virology"},{"issue":"18","key":"551_CR11","doi-asserted-by":"publisher","first-page":"10133","DOI":"10.1128\/JVI.78.18.10133-10148.2004","volume":"78","author":"TK Smit","year":"2004","unstructured":"Smit TK, Brew BJ, Tourtellotte W, Morgello S, Gelman BB, Saksena NK: Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment. Journal of Virology. 2004, 78 (18): 10133-10148. 10.1128\/JVI.78.18.10133-10148.2004.","journal-title":"Journal of Virology"},{"issue":"3","key":"551_CR12","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1128\/JVI.71.3.2059-2071.1997","volume":"71","author":"JK Wong","year":"1997","unstructured":"Wong JK, Ignacio CC, Torriani F, Havlir D, Fitch NJ, Richman DD: In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues. J Virol. 1997, 71 (3): 2059-2071.","journal-title":"J Virol"},{"issue":"10","key":"551_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2288-2-10","volume":"2","author":"NG Berman","year":"2002","unstructured":"Berman NG, Parker RA: Meta-analysis: neither quick nor easy. BMC Med Res Methodol. 2002, 2 (10): 10-","journal-title":"BMC Med Res Methodol"},{"issue":"8","key":"551_CR14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1212\/WNL.0b013e31820d8b0b","volume":"76","author":"L Garvey","year":"2011","unstructured":"Garvey L, Winston A, Walsh J, Post F, Porter K, Gazzard B, Fisher M, Leen C, Pillay D, Hill T, et al: Antiretroviral therapy CNS penetration and HIV-1-associated CNS disease. Neurology. 2011, 76 (8): 693-700. 10.1212\/WNL.0b013e31820d8b0b.","journal-title":"Neurology"},{"issue":"1","key":"551_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0895-4356(94)00096-9","volume":"48","author":"DJ Finney","year":"1995","unstructured":"Finney DJ: A statistician looks at met-analysis. J Clin Epidemiol. 1995, 48 (1): 87-103; discussion 105-108. 10.1016\/0895-4356(94)00096-9.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"551_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1198\/000313001300339897","volume":"55","author":"JM Hoenig","year":"2001","unstructured":"Hoenig JM, Heisey DM: The Abuse of Power: The Pervasive Fallacy of Power Calculations for Data Analysis. The American Statistician. 2001, 55 (1): 1-6. 10.1198\/000313001300339860.","journal-title":"The American Statistician"},{"issue":"4","key":"551_CR17","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","volume":"41","author":"F Faul","year":"2009","unstructured":"Faul F, Erdfelder E, Buchner A, Lang A-G: Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behavior Research Methods. 2009, 41 (4): 1149-1160. 10.3758\/BRM.41.4.1149.","journal-title":"Behavior Research Methods"},{"key":"551_CR18","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J: Statistical power analysis for the behavioral sciences. 1988, New York: Academic Press, 2","edition":"2"},{"key":"551_CR19","volume-title":"Sampling Techniques","author":"WG Cochran","year":"1977","unstructured":"Cochran WG: Sampling Techniques. 1977, Wiley Inc"},{"key":"551_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1355617706060401","volume":"12","author":"L Cysique","year":"2006","unstructured":"Cysique L, Maruff P, Brew B: The neuropsychological profile of symptomatic, AIDS and ADC patients in the pre-HAART era: a meta-analysis. Journal of the International Neuropsychological Society. 2006, 12: 1-15.","journal-title":"Journal of the International Neuropsychological Society"},{"issue":"2","key":"551_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11065-009-9092-3","volume":"19","author":"LA Cysique","year":"2009","unstructured":"Cysique LA, Brew BJ: Neuropsychological functioning and antiretroviral treatment in HIV\/AIDS: a review. Neuropsychol Rev. 2009, 19 (2): 169-185. 10.1007\/s11065-009-9092-3.","journal-title":"Neuropsychol Rev"},{"issue":"1","key":"551_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11481-006-9057-8","volume":"2","author":"S May","year":"2007","unstructured":"May S, Letendre S, Haubrich R, McCutchan JA, Heaton R, Capparelli E, Ellis R: Meeting practical challenges of a trial involving a multitude of treatment regimens: an example of a multi-center randomized controlled clinical trial in neuroAIDS. J Neuroimmune Pharmacol. 2007, 2 (1): 97-104. 10.1007\/s11481-006-9057-8.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1-2","key":"551_CR23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jneuroim.2004.08.025","volume":"157","author":"MJ Avison","year":"2004","unstructured":"Avison MJ, Nath A, Greene-Avison R, Schmitt FA, Greenberg RN, Berger JR: Neuroimaging correlates of HIV-associated BBB compromise. J Neuroimmunol. 2004, 157 (1-2): 140-146. 10.1016\/j.jneuroim.2004.08.025.","journal-title":"J Neuroimmunol"},{"issue":"10","key":"551_CR24","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1212\/WNL.0b013e3181f11bd8","volume":"75","author":"EJ Wright","year":"2010","unstructured":"Wright EJ, Grund B, Robertson K, Brew BJ, Roediger M, Bain MP, Drummond F, Vjecha MJ, Hoy J, Miller C, et al: Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. Neurology. 2010, 75 (10): 864-873. 10.1212\/WNL.0b013e3181f11bd8.","journal-title":"Neurology"},{"key":"551_CR25","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1097\/00002030-200209270-00003","volume":"16","author":"A Antinori","year":"2002","unstructured":"Antinori A, Giancola ML, Grisetti S, Soldani F, Alba L, Liuzzi G: Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients. AIDS. 2002, 16: 1867-1876. 10.1097\/00002030-200209270-00003.","journal-title":"AIDS"},{"issue":"1","key":"551_CR26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/135965350300800103","volume":"8","author":"L Chang","year":"2003","unstructured":"Chang L, Ernst T, Witt MD, Ames N, Walot I, Jovicich J, DeSilva M, Trivedi N, Speck O, Miller EN: Persistent brain abnormalities in antiretroviral-naive HIV patients 3 months after HAART. Antivir Ther. 2003, 8 (1): 17-26.","journal-title":"Antivir Ther"},{"issue":"11","key":"551_CR27","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1001\/archneur.61.11.1699","volume":"61","author":"L Cysique","year":"2004","unstructured":"Cysique L, Maruff P, Brew B: Antiretroviral therapy in HIV infection: are neurologically active drugs important?. Archives of Neurology. 2004, 61 (11): 1699-1704. 10.1001\/archneur.61.11.1699.","journal-title":"Archives of Neurology"},{"issue":"9","key":"551_CR28","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1212\/01.wnl.0000210477.63851.d3","volume":"66","author":"LA Cysique","year":"2006","unstructured":"Cysique LA, Maruff P, Brew BJ: Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology. 2006, 66 (9): 1447-1450. 10.1212\/01.wnl.0000210477.63851.d3.","journal-title":"Neurology"},{"issue":"5","key":"551_CR29","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1212\/WNL.0b013e3181ab2b3b","volume":"73","author":"LA Cysique","year":"2009","unstructured":"Cysique LA, Vaida F, Letendre S, Gibson S, Cherner M, Woods SP, McCutchan JA, Heaton RK, Ellis RJ: Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology. 2009, 73 (5): 342-348. 10.1212\/WNL.0b013e3181ab2b3b.","journal-title":"Neurology"},{"key":"551_CR30","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1212\/WNL.59.3.342","volume":"59","author":"A De Luca","year":"2002","unstructured":"De Luca A, Ciancio BC, Larussa D, Murri R, Cingolani A, Rizzo MG, Giancola ML, Ammassari A, Ortona L: Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals. Neurology. 2002, 59: 342-347.","journal-title":"Neurology"},{"issue":"13","key":"551_CR31","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1097\/00002030-200309050-00008","volume":"17","author":"C Eggers","year":"2003","unstructured":"Eggers C, Hertogs K, Sturenburg HJ, van Lunzen J, Stellbrink HJ: Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration. Aids. 2003, 17 (13): 1897-1906. 10.1097\/00002030-200309050-00008.","journal-title":"Aids"},{"key":"551_CR32","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1212\/01.WNL.0000058768.73358.1A","volume":"60","author":"CM Marra","year":"2003","unstructured":"Marra CM, Lockhart D, Zunt JR, Perrin M, Coombs RW, Collier AC: Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy. Neurology. 2003, 60: 1388-1390.","journal-title":"Neurology"},{"issue":"11","key":"551_CR33","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1097\/QAD.0b013e32832c4152","volume":"23","author":"CM Marra","year":"2009","unstructured":"Marra CM, Zhao Y, Clifford DB, Letendre S, Evans S, Henry K, Ellis RJ, Rodriguez B, Coombs RW, Schifitto G, et al: Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. Aids. 2009, 23 (11): 1359-1366. 10.1097\/QAD.0b013e32832c4152.","journal-title":"Aids"},{"issue":"3","key":"551_CR34","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/ana.20198","volume":"56","author":"S Letendre","year":"2004","unstructured":"Letendre S, McCutchan J, Childers M, Woods S, Lazzaretto D, Heaton R, Grant I, Ellis R, Group. H: Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Annals of Neurology. 2004, 56 (3): 416-423. 10.1002\/ana.20198.","journal-title":"Annals of Neurology"},{"issue":"1","key":"551_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/archneurol.2007.31","volume":"65","author":"S Letendre","year":"2008","unstructured":"Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, et al: Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol. 2008, 65 (1): 65-70. 10.1001\/archneurol.2007.31.","journal-title":"Arch Neurol"},{"issue":"14","key":"551_CR36","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1097\/QAD.0b013e32832dc041","volume":"23","author":"K Patel","year":"2009","unstructured":"Patel K, Ming X, Williams PL, Robertson KR, Oleske JM, Seage GR: Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents. Aids. 2009, 23 (14): 1893-1901. 10.1097\/QAD.0b013e32832dc041.","journal-title":"Aids"},{"key":"551_CR37","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1212\/WNL.57.3.542","volume":"57","author":"N Sacktor","year":"2001","unstructured":"Sacktor N, Tarwater PM, Skolasky RL, McArthur J, Selnes OA, Becker J, Cohen B, Miller EN: CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing. Neurology. 2001, 57: 542-544.","journal-title":"Neurology"},{"key":"551_CR38","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1212\/01.WNL.0000145763.68284.15","volume":"63","author":"JJ Sevigny","year":"2004","unstructured":"Sevigny JJ, Albert SM, McDermott MP, McArthur JC, Sacktor N, Conant K, Schifitto G, Selnes OA, Stern Y, McClernon DR, et al: Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology. 2004, 63: 2084-2090.","journal-title":"Neurology"},{"issue":"3","key":"551_CR39","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/QAD.0b013e32834171f8","volume":"25","author":"M Smurzynski","year":"2011","unstructured":"Smurzynski M, Wu K, Letendre S, Robertson K, Bosch RJ, Clifford DB, Evans S, Collier AC, Taylor M, Ellis R: Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort. AIDS. 2011, 25 (3): 357-365. 10.1097\/QAD.0b013e32834171f8.","journal-title":"AIDS"},{"issue":"1","key":"551_CR40","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/QAI.0b013e3181af83d6","volume":"52","author":"V Tozzi","year":"2009","unstructured":"Tozzi V, Balestra P, Salvatori MF, Vlassi C, Liuzzi G, Giancola ML, Giulianelli M, Narciso P, Antinori A: Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders. J Acquir Immune Defic Syndr. 2009, 52 (1): 56-63. 10.1097\/QAI.0b013e3181af83d6.","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-11-148.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2377-11-148\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-11-148","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T07:58:43Z","timestamp":1686470323000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/1471-2377-11-148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,22]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["551"],"URL":"https:\/\/doi.org\/10.1186\/1471-2377-11-148","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,22]]},"article-number":"148"}}